Cubist Systematic Strategies’s Silence Therapeutics SLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,364
| Closed | -$20.8K | – | 2247 |
|
|
2025
Q1 | $20.8K | Sell |
7,364
-98,956
| -93% | -$279K | ﹤0.01% | 1347 |
|
|
2024
Q4 | $731K | Buy |
106,320
+60,015
| +130% | +$413K | ﹤0.01% | 889 |
|
|
2024
Q3 | $842K | Buy |
46,305
+36,867
| +391% | +$670K | 0.01% | 858 |
|
|
2024
Q2 | $179K | Sell |
9,438
-26,843
| -74% | -$510K | ﹤0.01% | 1103 |
|
|
2024
Q1 | $784K | Buy |
+36,281
| New | +$784K | ﹤0.01% | 1238 |
|
|
2023
Q2 | – | Sell |
-2,600
| Closed | -$16.1K | – | 2950 |
|
|
2023
Q1 | $16.1K | Buy |
+2,600
| New | +$16.1K | ﹤0.01% | 2643 |
|
|
2022
Q4 | – | Sell |
-500
| Closed | -$5K | – | 3557 |
|
|
2022
Q3 | $5K | Buy |
+500
| New | +$5K | ﹤0.01% | 3516 |
|
|
2022
Q1 | – | Sell |
-184
| Closed | -$4K | – | 3727 |
|
|
2021
Q4 | $4K | Buy |
+184
| New | +$4K | ﹤0.01% | 3412 |
|